Psilocybin is the scientific name for magic mushrooms. MDMA is the scientific name for Ecstacy, and Vitamin K or ketamine was an anesthesia used originally for animals and also on the battlefields during the Vietnam War. There are many more psychedelics such as LSD, DMT, and ayahuasca. Most are made from plants, and they can also be made in laboratories. Ketamine clinics in the U.S. number over 400 and counting.
Considerable venture capital money is being invested in these medicines, with over $200 million so far. Advocates believe they are providing the only form of relief for many patients with anxiety, migraines, cluster headaches, depression, severe PTSD and suicidal dispositions, and alcohol and opioid additions. Mental health is vital to the wellness and survival of families, businesses, economies, and countries. Last month, Numinous (TSE: NUMI) acquired Novamind in an effort to address mental health needs most effectively. A California bill to legalize psychedelics, SB 519 has strong support from many in the healthcare profession and those in the military, as the plant medicine has had good results in treating PTSD.
